Sergio Sosa‐Estáni

6.9k total citations · 1 hit paper
81 papers, 3.8k citations indexed

About

Sergio Sosa‐Estáni is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Infectious Diseases. According to data from OpenAlex, Sergio Sosa‐Estáni has authored 81 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Epidemiology, 41 papers in Public Health, Environmental and Occupational Health and 12 papers in Infectious Diseases. Recurrent topics in Sergio Sosa‐Estáni's work include Trypanosoma species research and implications (61 papers), Research on Leishmaniasis Studies (39 papers) and Synthesis and Biological Evaluation (7 papers). Sergio Sosa‐Estáni is often cited by papers focused on Trypanosoma species research and implications (61 papers), Research on Leishmaniasis Studies (39 papers) and Synthesis and Biological Evaluation (7 papers). Sergio Sosa‐Estáni collaborates with scholars based in Argentina, United States and Switzerland. Sergio Sosa‐Estáni's co-authors include Elsa L. Segura, Anis Rassi, Yves Carlier, Pierre Buekens, Carlos A. Morillo, Felipe Guhl, José Antônio Marin‐Neto, Elsa Velázquez, Salim Yusuf and Álvaro Avezum and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Sergio Sosa‐Estáni

80 papers receiving 3.8k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized Trial of Benznidazole for Chronic Chagas’ Cardiomyopathy

2015 719 citations Carlos A. Morillo, Sergio Sosa‐Estáni et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sergio Sosa‐Estáni Argentina	30	3.3k	2.3k	589	577	445	81	3.8k
Louis V. Kirchhoff United States	40	3.7k 1.1×	2.6k 1.1×	328 0.6×	1.0k 1.8×	495 1.1×	74	4.9k
Susan P. Montgomery United States	39	3.1k 1.0×	3.2k 1.4×	386 0.7×	2.3k 3.9×	517 1.2×	110	6.1k
Yves Carlier Belgium	39	3.2k 1.0×	2.2k 1.0×	264 0.4×	1.3k 2.3×	266 0.6×	141	4.8k
Johannes Blum Switzerland	29	1.6k 0.5×	1.9k 0.8×	240 0.4×	939 1.6×	242 0.5×	76	3.2k
José Rodrigues Coura Brazil	35	4.3k 1.3×	3.6k 1.6×	749 1.3×	1.5k 2.6×	1.1k 2.4×	138	5.8k
Maria Aparecida Shikanai‐Yasuda Brazil	36	3.1k 0.9×	1.3k 0.6×	217 0.4×	663 1.1×	246 0.6×	140	3.7k
Isabela Ribeiro Switzerland	27	1.5k 0.5×	1.4k 0.6×	464 0.8×	304 0.5×	213 0.5×	52	2.1k
Elena Sulleiro Spain	24	1.1k 0.3×	1.1k 0.5×	248 0.4×	649 1.1×	141 0.3×	146	2.2k
María‐Jesús Pinazo Spain	32	2.6k 0.8×	2.0k 0.9×	555 0.9×	663 1.1×	322 0.7×	115	3.2k
Vicente Amato Neto Brazil	30	1.7k 0.5×	1.6k 0.7×	252 0.4×	913 1.6×	140 0.3×	243	2.9k

Countries citing papers authored by Sergio Sosa‐Estáni

Since Specialization

Citations

This map shows the geographic impact of Sergio Sosa‐Estáni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio Sosa‐Estáni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio Sosa‐Estáni more than expected).

Fields of papers citing papers by Sergio Sosa‐Estáni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergio Sosa‐Estáni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio Sosa‐Estáni. The network helps show where Sergio Sosa‐Estáni may publish in the future.

Co-authorship network of co-authors of Sergio Sosa‐Estáni

This figure shows the co-authorship network connecting the top 25 collaborators of Sergio Sosa‐Estáni. A scholar is included among the top collaborators of Sergio Sosa‐Estáni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergio Sosa‐Estáni. Sergio Sosa‐Estáni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fernández, Marisa, Omar Sued, Santiago Perez‐Lloret, et al.. (2025). Pharmacokinetics of two pharmaceutical presentations of benznidazole in adult Trypanosoma cruzi infected population. Memórias do Instituto Oswaldo Cruz. 120. e240177–e240177.

Pinazo, María‐Jesús, Colin Forsyth, Constanza Lopez-Albízu, et al.. (2023). Clinical use of molecular methods for Trypanosoma cruzi infection in endemic and non-endemic countries: Benefits, limitations and challenges. SHILAP Revista de lepidopterología. 2. 1241154–1241154. 3 indexed citations

Dahal, Prabin, Sumayyah Rashan, Colin Forsyth, et al.. (2021). The Chagas disease study landscape: A systematic review of clinical and observational antiparasitic treatment studies to assess the potential for establishing an individual participant-level data platform. PLoS neglected tropical diseases. 15(8). e0009697–e0009697. 19 indexed citations

Zaidel, Ezequiel, Colin Forsyth, Rachel Marcus, et al.. (2020). COVID-19: Implications for People with Chagas Disease. Global Heart. 15(1). 69–69. 36 indexed citations

Fernández, Marisa, Pau Bosch‐Nicolau, Elena Sulleiro, et al.. (2020). Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II superiority clinical trial. Trials. 21(1). 328–328. 39 indexed citations

Alvar, Jorge, Fabiana Alves, Bruno Bucheton, et al.. (2020). Implications of asymptomatic infection for the natural history of selected parasitic tropical diseases. Seminars in Immunopathology. 42(3). 231–246. 36 indexed citations

Alvarez, M, Juan Carlos Ramı́rez, Graciela Bertocchi, et al.. (2020). New Scheme of Intermittent Benznidazole Administration in Patients Chronically Infected with Trypanosoma cruzi: Clinical, Parasitological, and Serological Assessment after Three Years of Follow-Up. Antimicrobial Agents and Chemotherapy. 64(9). 20 indexed citations

Echeverría, Luis Eduardo, Rachel Marcus, Sergio Sosa‐Estáni, et al.. (2020). WHF IASC Roadmap on Chagas Disease. Global Heart. 15(1). 26–26. 85 indexed citations

Kratz, Jadel M., Facundo García‐Bournissen, Colin Forsyth, & Sergio Sosa‐Estáni. (2018). Clinical and pharmacological profile of benznidazole for treatment of Chagas disease. Expert Review of Clinical Pharmacology. 11(10). 943–957. 92 indexed citations

10.

Colantonio, Lisandro D., et al.. (2016). Electrocardiographic Abnormalities and Treatment with Benznidazole among Children with Chronic Infection by Trypanosoma cruzi: A Retrospective Cohort Study. PLoS neglected tropical diseases. 10(5). e0004651–e0004651. 12 indexed citations

11.

Pinazo, María‐Jesús, M. Carmen Thomas, Jacqueline Búa, et al.. (2014). Biological markers for evaluating therapeutic efficacy in Chagas disease, a systematic review. Expert Review of Anti-infective Therapy. 12(4). 479–496. 79 indexed citations

12.

Escobar, Gabriela I., et al.. (2008). BRUCELOSIS CANINA EN PERROS DE LA CIUDAD DE BUENOS AIRES. LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas). 68(4). 291–297. 8 indexed citations

13.

Rivas, M, E Miliwebsky, Isabel Chinen, et al.. (2006). Characterization and Epidemiologic Subtyping of Shiga Toxin–Producing Escherichia coli Strains Isolated from Hemolytic Uremic Syndrome and Diarrhea Cases in Argentina. Foodborne Pathogens and Disease. 3(1). 88–96. 125 indexed citations

14.

Sosa‐Estáni, Sergio, Diana Rossi, & Mercedes Weissenbacher. (2003). Epidemiology of Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome in Injection Drug Users in Argentina: High Seroprevalence of HIV Infection. Clinical Infectious Diseases. 37(s5). S338–S342. 21 indexed citations

15.

Salomón, Oscar Daniel, Sergio Sosa‐Estáni, Gustavo Carlos Rossi, & Gustavo R. Spinelli. (2001). Presencia de Lutzomyia longipalpis y situación de la leishmaniosis visceral en Argentina. Americanae (AECID Library). 29 indexed citations

16.

Salomón, Oscar Daniel, et al.. (2001). Leishmaniosis tegumentaria en un área con niveles epidémicos de transmisión, Salta, Argentina, 1998. Americanae (AECID Library). 22 indexed citations

17.

Salomón, Oscar Daniel, et al.. (2001). Brote epidémico de leishmaniosis tegumentaria en Puerto Esperanza, provincia de Misiones, 1998. Americanae (AECID Library). 15 indexed citations

18.

Sosa‐Estáni, Sergio, et al.. (2001). [Regional differences and Hantavirus pulmonary syndrome].. PubMed. 17 Suppl. 47–57. 5 indexed citations

19.

Sosa‐Estáni, Sergio, E. Cura, & E L Segura. (2000). Treatment with benznidazole in children in the indeterminate phase of infection with Trypanosoma cruzi. Long-term study.. Revista da Sociedade Brasileira de Medicina Tropical. 33. 40–41. 1 indexed citations

20.

Sosa‐Estáni, Sergio, et al.. (1999). Control de la transmisión de Trypanosoma cruzi en la Argentina 1999. Americanae (AECID Library). 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact